| Literature DB >> 36182963 |
Montserrat Rodríguez-Ayala1,2, José Ramón Banegas1, Rosario Ortolá1, Manuel Gorostidi3, Carolina Donat-Vargas1,4,5,6, Fernando Rodríguez-Artalejo1,7, Pilar Guallar-Castillón8,9.
Abstract
Evidence of the role of cooking methods on inflammation and metabolic health is scarce due to the paucity of large-size studies. Our aim was to evaluate the association of cooking methods with inflammatory markers, renal function, and other hormones and nutritional biomarkers in a general population of older adults. In a cross sectional analysis with 2467 individuals aged ≥ 65, dietary and cooking information was collected using a validated face-to-face dietary history. Eight cooking methods were considered: raw, boiling, roasting, pan-frying, frying, toasting, sautéing, and stewing. Biomarkers were analyzed in a central laboratory following standard procedures. Marginal effects from generalized linear models were calculated and percentage differences (PD) of the multivariable-adjusted means of biomarkers between extreme sex-specific quintiles (Q) of cooking methods consumption were computed ([Q5 - Q1/Q1] × 100). Participants' mean age was 71.6 years (53% women). Significant PD for the highest vs lowest quintile of raw food consumption was - 54.7% for high sensitivity-C reactive protein (hs-CRP), - 11.9% for neutrophils, - 11.9% for Growth Differentiation Factor-15, - 25.0% for Interleukin-6 (IL-6), - 12.3% for urinary albumin, and - 10.3% for uric acid. PD for boiling were - 17.8% for hs-CRP, - 12.4% for urinary albumin, and - 11.3% for thyroid-stimulating hormone. Concerning pan-frying, the PD was - 23.2% for hs-CRP, - 11.5% for IL-6, - 16.3% for urinary albumin and 10.9% for serum vitamin D. For frying, the PD was a 25.7% for hs-CRP, and - 12.6% for vitamin D. For toasting, corresponding figures were - 21.4% for hs-CRP, - 11.1% for IL-6 and 10.6% for vitamin D. For stewing, the PD was 13.3% for hs-CRP. Raw, boiling, pan-frying, and toasting were associated with healthy profiles as for inflammatory markers, renal function, thyroid hormones, and serum vitamin D. On the contrary, frying and, to a less extent, stewing showed unhealthier profiles. Cooking methods not including added fats where healthier than those with added fats heated at high temperatures or during longer periods of time.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36182963 PMCID: PMC9526743 DOI: 10.1038/s41598-022-19716-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Baseline characteristics of participants in extreme quintiles of cooking methods. The Seniors-ENRICA 2 Study (N = 2467).
| Raw | Boiling | Roasting | Pan-frying | Frying | Toasting | Sautéing | Stewing | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q5 | Q1 | Q5 | Q1 | Q5 | Q1 | Q5 | Q1 | Q5 | Q1 | Q5 | Q1 | Q5 | Q1 | Q5 | |
| Age, mean, y | 71.7 | 71.6 | 71.6 | 71.8 | 72.3 | 70.4‡ | 72.3 | 71.1‡ | 71.3 | 72.0* | 71.7 | 71.6 | 71.9 | 71.6* | 71.6 | 71.3 |
| Women, (%) | 53.0 | 53.1 | 53.0 | 53.1 | 53.0 | 53.1 | 53.0 | 53.1 | 53.0 | 53.1 | 46.3 | 53.1‡ | 53.0 | 53.1 | 53.0 | 53.1 |
| Primary or less | 64.8 | 58.7 | 55.9 | 64.2† | 54.7 | 67.9‡ | 66.6 | 62.0 | 53.2 | 73.6‡ | 69.0 | 55.1‡ | 58.7 | 60.8† | 59.7 | 64.0* |
| Secondary | 17.8 | 19.5 | 20.6 | 19.5 | 20.9 | 18.3‡ | 16.4 | 19.1 | 21.7 | 13.6 | 17.2 | 20.1 | 17.4 | 20.7 | 17.2 | 17.9 |
| University | 17.4 | 21.8 | 23.5 | 16.3 | 24.5 | 13.8‡ | 17.0 | 18.9 | 25.1 | 12.8 | 13.7 | 24.8 | 23.9 | 18.5 | 23.1 | 18.1 |
| Current | 12.5 | 6.71* | 10.7 | 8.13† | 7.5 | 11.6† | 11.9 | 7.3 | 7.50 | 12.4‡ | 13.1 | 5.3† | 6.88 | 10.8 | 9.31 | 9.55 |
| Former | 38.9 | 39.2 | 39.3 | 34.6 | 43.7 | 32.3 | 37.7 | 41.5 | 43.3 | 31.7 | 37.4 | 40.0 | 41.5 | 38.2 | 39.3 | 39.0 |
| Never | 48.6 | 54.1 | 50.0 | 57.3 | 48.8 | 56.1 | 50.4 | 51.2 | 49.2 | 55.9 | 49.5 | 54.7 | 51.6 | 51.0 | 51.4 | 51.4 |
| Alcohol consumption, median, g/d | 3.17 | 1.96 | 3.7 | 0.9‡ | 2.2 | 1.1‡ | 1.9 | 1.2 | 1.7 | 2.9* | 2.7 | 1.8 | 3.5 | 1.8* | 2.1 | 2.6 |
| Former-drinker status, (%) | 10.1 | 11.0 | 7.3 | 13.8† | 10.3 | 11.6 | 10.9 | 11.0 | 12.6 | 10.0 | 10.3 | 10.6 | 8.10 | 8.94* | 11.3 | 10.2 |
| RPA1, median, METs·h/week | 19.5 | 25.5‡ | 22.5 | 25.0 | 23.8 | 24.9 | 21.5 | 25.0† | 24.6 | 25.5 | 22.5 | 25.0† | 21.5 | 25* | 21.5 | 25.0* |
| HPA2, median, METs·h/week | 35.0 | 35.0 | 33.5 | 35.0 | 31.5 | 35.0* | 35.0 | 35.0 | 34.0 | 36.8† | 35.0 | 35.0 | 31.0 | 35.0* | 35.0 | 35.0 |
| Hours of television, median | 23.9 | 20.3‡ | 22.9 | 21.7 | 21.4 | 22.4 | 23.2 | 21.3 | 21.8 | 22.3 | 22.8 | 20.8* | 21.9 | 21.4 | 22.3 | 22.4 |
| No. chronic diseases, median | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| No. medications, median | 3.0 | 2.0‡ | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 2.0‡ | 3.0 | 3.0 | 3.0 | 3.0 |
| Energy intake, mean, kcal/d | 2364.0 | 2385.9* | 2249.6 | 2507.6‡ | 2276.0 | 2446.9‡ | 2438.0 | 2292.8‡ | 2213.7 | 2526.7‡ | 2377.5 | 2395.3* | 2325.9 | 2405.0 | 2270.3 | 2439.7‡ |
| Omega-3, median, g/d | 0.486 | 0.595‡ | 0.529 | 0.533 | 0.545 | 0.527 | 0.386 | 0.779‡ | 0.460 | 0.683‡ | 0.512 | 0.546 | 0.519 | 0.547 | 0.539 | 0.612 |
| Fiber, mean, g/d | 25.8 | 35.3‡ | 26.7 | 34.9‡ | 30.1 | 30.9 | 30.1 | 30.6 | 30.0 | 30.8 | 28.9 | 32.1‡ | 31.2 | 30.2 | 29.6 | 30.9† |
Q1 = Quintile 1 (lowest); Q5 = Quintile 5 (highest). Kruskal–Wallis test was used for comparisons between continuous variables and Pearson's Chi-square for categorical variables.
1RPA: recreational physical activity.
2HPA: household physical activity.
*p < 0.05; †p < 0.01; ‡p < 0.001.
Percentage differences (PD) of inflammatory factors, renal function, and other hormones and nutritional biomarkers among cooking methods.
| Outcome variables | Cooking methods | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Raw | Boiling | Roasting | Pan-frying | Frying | Toasting | Sautéing | Stewing | |||||||||
| PD | PD | PD | PD | PD | PD | PD | PD | |||||||||
| hs-CRP* | − 54.7 | < 0.001 | − 17.8 | 0.045 | − 5.2 | 0.302 | − 23.2 | 0.103 | 25.7 | 0.217 | − 21.4 | 0.047 | − 1.0 | 0.483 | 13.3 | 0.817 |
| WBC | − 9.1 | 0.001 | − 3.9 | 0.144 | − 0.7 | 0.576 | − 1.4 | 0.549 | 3.0 | 0.406 | − 5.7 | 0.264 | 1.2 | 0.958 | − 3.2 | 0.034 |
| Neutrophils | − 11.9 | 0.002 | − 5.9 | 0.045 | − 1.5 | 0.181 | − 3.0 | 0.831 | 4.1 | 0.185 | − 7.3 | 0.253 | 0.0 | 0.316 | − 2.1 | 0.273 |
| Lymphocytes | − 2.9 | 0.08 | − 1.8 | 0.766 | 0.0 | 0.483 | 1.8 | 0.363 | 1.2 | 0.955 | − 2.3 | 0.985 | 3.6 | 0.079 | − 4.5 | 0.021 |
| Platelets | − 5.5 | 0.025 | − 0.7 | 0.29 | 1.2 | 0.087 | − 2.1 | 0.384 | 1.7 | 0.488 | − 1.1 | 0.637 | − 1.2 | 0.294 | 0.3 | 0.788 |
| GDF-15 | − 11.9 | 0.028 | − 0.3 | 0.42 | 2.6 | 0.924 | − 6.8 | 0.742 | 5.3 | 0.008 | − 8.0 | 0.857 | − 5.7 | 0.041 | − 4.3 | 0.688 |
| IL-6 | − 25.0 | 0.001 | − 4.0 | 0.139 | 8.3 | 0.800 | − 11.5 | 0.404 | 4.2 | 0.978 | − 11.1 | 0.009 | 0.0 | 0.851 | 4.0 | 0.777 |
| Serum creatinine | − 2.5 | 0.075 | − 2.5 | 0.317 | 0.9 | 0.355 | − 3.8 | 0.201 | 1.3 | 0.317 | − 1.8 | 0.782 | − 3.4 | 0.004 | − 1.3 | 0.976 |
| CKD-EPI | 2.1 | 0.044 | 0.8 | 0.213 | 0.1 | 0.134 | 2.3 | 0.794 | − 1.7 | 0.197 | 1.5 | 0.636 | 2.5 | 0.020 | 1.7 | 0.243 |
| Urinary albumin* | − 12.3 | 0.359 | − 12.4 | 0.155 | − 9.2 | 0.034 | − 16.3 | 0.904 | 0.9 | 0.602 | − 4.7 | 0.841 | − 4.6 | 0.376 | 0.0 | 0.880 |
| Serum uric acid* | − 10.3 | < 0.001 | − 9.2 | < 0.001 | − 8.6 | 0.003 | − 4.2 | 0.204 | − 2.7 | 0.159 | − 3.8 | 0.253 | − 4.7 | 0.003 | 1.0 | 0.035 |
| Serum sodium* | 0.2 | 0.008 | − 0.1 | 0.357 | 0.1 | 0.931 | 0.0 | 0.951 | 0.0 | 0.438 | 0.1 | 0.354 | 0.1 | 0.074 | 0.0 | 0.558 |
| Serum potassium* | − 2.9 | < 0.001 | 3.7 | 0.003 | 2.5 | 0.016 | − 0.4 | 0.316 | 3.9 | 0.001 | 0.2 | 0.726 | − 1.0 | 0.239 | 0.5 | 0.715 |
| TSH* | 9.6 | 0.146 | − 11.3 | 0.118 | 8.2 | 0.479 | − 7.3 | 0.473 | 5.6 | 0.094 | − 1.8 | 0.611 | 3.7 | 0.982 | − 3.5 | 0.320 |
| Vitamin D* | 8.9 | 0.282 | 7.2 | 0.007 | − 2.7 | 0.438 | 10.9 | 0.033 | − 12.6 | 0.065 | 10.6 | 0.045 | 3.5 | 0.202 | 4.5 | 0.252 |
| Serum albumin* | 1.4 | 0.118 | − 1.2 | 0.005 | − 0.2 | 0.267 | 0.0 | 0.376 | 0.2 | 0.286 | − 0.2 | 0.964 | 0.0 | 0.485 | − 0.5 | 0.937 |
| Serum total protein | 0.3 | 0.934 | 0.3 | 0.768 | − 0.6 | 0.233 | − 0.3 | 0.938 | − 0.7 | 0.022 | − 0.1 | 0.718 | 0.1 | 0.121 | 0.1 | 0.690 |
PD: percentage difference; measured as a difference between quintile 5 and quintile 1 divided by quintile 1. Hs-CRP: high sensitivity-C reactive protein; WBC: white blood cells; GDF-15: Growth differentiation factor 15; IL-6: Interleukin 6; CKD-EPI: Chronic Kidney Disease-Epidemiology Collaboration equation; TSH: Thyroid-stimulating hormone.
*Calculated in the nested subsample (n = 1066).
p: p linear for trend of outcome variables when quintiles of consumption were used as a continuous variable in the model adjusted for all possible confounding variables (sex, age (continuous), energy intake (continuous), educational level (primary or less, secondary, university), smoking status (former, current, never), alcohol consumption (continuous), former-drinker status (yes, no), recreational physical activity in METs·hours/week (continuous), household physical activity in METs·hours/week (continuous), hours of television (continuous), number of chronic diseases (continuous), number of prescribed medications (continuous), very long chain omega-3 fatty acids (continuous), and fiber (continuous) consumption.